Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Morabito

Showing results (21-30 of 198) with videos related to

Pageof 20
Sort By:
Oncology Reports|December 5, 2003
Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaAlessandro Morabito, Massimo Fanelli, Guido Carillio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?Alessandro Morabito, Maria Carmela Piccirillo, Ermelinda De Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2007
Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinibGermano Zampa, Michele Moscato, Brian W Brannigan, et al.
Frontiers in Medicine|January 10, 2017
Focus on Nintedanib in NSCLC and Other TumorsAnna Manzo, Guido Carillio, Agnese Montanino, et al.
Journal of Thoracic Disease|October 29, 2014
Validation of the new IASLC/ATS/ERS lung adenocarcinoma classification: a surgeon's perspectiveRaffaele Rocco, David R Jones, Alessandro Morabito, et al.
Pathogens (Basel, Switzerland)|December 31, 2025
Staphylococci: What Has Changed in the Antibiotic Resistance Profile in the Last Decade-Analysis of Strains Isolated from Hospitalised PatientsAlessio Facciolà, Antonio Laganà, Maria Eufemia Gioffrè, et al.
Clinical Breast Cancer|March 15, 2003
Prognostic and predictive indicators in operable breast cancerAlessandro Morabito, Elena Magnani, Massimo Gion, et al.
Journal of Circulating Biomarkers|July 12, 2021
Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoringVittoria Barchiesi, Vittorio Simeon, Claudia Sandomenico, et al.
Critical Reviews in Oncology/Hematology|December 25, 2016
New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working GroupDiego Cortinovis, Vanesa Gregorc, Maria Rita Migliorino, et al.
Cancers|November 11, 2022
KRAS in NSCLC: State of the Art and Future PerspectivesPriscilla Cascetta, Arianna Marinello, Chiara Lazzari, et al.
Pageof 20

Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
Oncology Reports|December 5, 2003
Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastomaAlessandro Morabito, Massimo Fanelli, Guido Carillio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?Alessandro Morabito, Maria Carmela Piccirillo, Ermelinda De Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|December 15, 2007
Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinibGermano Zampa, Michele Moscato, Brian W Brannigan, et al.
Frontiers in Medicine|January 10, 2017
Focus on Nintedanib in NSCLC and Other TumorsAnna Manzo, Guido Carillio, Agnese Montanino, et al.
Journal of Thoracic Disease|October 29, 2014
Validation of the new IASLC/ATS/ERS lung adenocarcinoma classification: a surgeon's perspectiveRaffaele Rocco, David R Jones, Alessandro Morabito, et al.
Pathogens (Basel, Switzerland)|December 31, 2025
Staphylococci: What Has Changed in the Antibiotic Resistance Profile in the Last Decade-Analysis of Strains Isolated from Hospitalised PatientsAlessio Facciolà, Antonio Laganà, Maria Eufemia Gioffrè, et al.
Clinical Breast Cancer|March 15, 2003
Prognostic and predictive indicators in operable breast cancerAlessandro Morabito, Elena Magnani, Massimo Gion, et al.
Journal of Circulating Biomarkers|July 12, 2021
Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoringVittoria Barchiesi, Vittorio Simeon, Claudia Sandomenico, et al.
Critical Reviews in Oncology/Hematology|December 25, 2016
New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working GroupDiego Cortinovis, Vanesa Gregorc, Maria Rita Migliorino, et al.
Cancers|November 11, 2022
KRAS in NSCLC: State of the Art and Future PerspectivesPriscilla Cascetta, Arianna Marinello, Chiara Lazzari, et al.
Pageof 20